Seminars in Pediatric Neurology
Volume 16, Issue 4 , Pages 179-190 , December 2009

The Encephalopathy of Prematurity: One Pediatric Neuropathologist's Perspective

  • Hannah C. Kinney, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Hannah C. Kinney, MD, Department of Pathology, Enders Building 1112, Children's Hospital Boston, 300 Longwood Av, Boston, MA 02115

References 

  1. Volpe JJ. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8:110–124
  2. Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics. 2005;116:221–225
  3. Kinney HC, Volpe JJ. Perinatal panencephalopathy in premature infants: is it due to hypoxia-ischemia?. In:  Haddad GG,  Yu SP editor. Brain Hypoxia and Ischemia with Special Emphasis on Development. New York: Humana Press; 2009;p. 153–186
  4. Friede RL. Developmental Neuropathology. In: New York: Springer-Verlag; 1989;p. 69–114
  5. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy (A form of neonatal anoxic encephalopathy). Arch Neurol. 1962;7:386–410
  6. Leviton A, Gilles FH. Acquired perinatal leukoencephalopathy. Ann Neurol. 1984;16:1–8
  7. Gilles FH, Leviton A, Dooling EC, et al. The Developing Human Brain (Growth and Epidemiologic Neuropathology). Littleton, MA: Wright-PSG; 1983;
  8. Gilles FH, Leviton A, Kerr CS, et al. Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 1976;27:183–191
  9. Volpe JJ. Cerebral white matter injury of the premature infant—more common than you think. Pediatrics. 2003;112:176–179
  10. Kinney HC, Armstrong DL. Perinatal neuropathology. In:  Graham DI,  Lantos PE editor. Greenfield's Neuropathology. (ed 7). London, UK: Arnold Publishers; 2002;p. 519–606
  11. Haynes RL, Folkerth RD, Keefe R, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes is accompanied by microglial activation in periventricular leukomalacia in the human premature infant. J Neuropathol Exp Neurol. 2003;62:441–450
  12. Billiards SS, Haynes RL, Folkerth RD, et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008;18:153–163
  13. Haynes RL, Billiards SS, Borenstein NS, et al. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res. 2008;63:656–661
  14. Pierson CR, Folkerth RD, Billiards SS, et al. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol. 2007;114:619–631
  15. Ligam P, Haynes RL, Folkerth RD, et al. Thalamic damage in periventricular leukomalacia: Novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr Res. 2009;65:524–529
  16. Folkerth RD, Keefe RJ, Haynes RL, et al. Interferon-γ expression in periventricular leukomalacia in the human brain. Brain Pathol. 2004;14:265–274
  17. DeSilva TM, Billiards SS, Borenstein NS, et al. Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in periventricular leukomalacia. J Comp Neurol. 2008;508:238–248
  18. Kinney HC. The late pre-term (near-term) human brain and risk for periventricular leukomalacia: A review. Semin Perinatol. 2006;30:81–88
  19. Billiards SS, Pierson CR, Haynes RL, et al. Is the late preterm brain more vulnerable to gray matter injury than the term brain?. Clin Perinatol. 2006;33:915–934
  20. Haynes RL, Trachtenberg FL, Volpe JJ, et al: Regeneration of white matter neurons in periventricular leukomalacia. Presented at the Annual meeting of the Society for Neuroscience, October, 2009, Chicago, IL (abstract)
  21. Haynes RL, Folkerth RD, Trachtenberg FL, et al. Nitrative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathol. 2009;118:391–399
  22. Andiman SE, Haynes RL, Folkerth RD, et al. Loss of white matter neurons in periventricular leukomalacia: Implications for cognitive deficits in survivors of prematurity. Soc Neurosci. 2009;(abstract)
  23. Back SA, Luo NL, Mallinson RA, et al. Selective vulnerability of preterm white matter to oxidative damage defined by F(2)-isoprostanes. Ann Neurol. 2005;58:108–120
  24. Iida K, Takashima S, Ueda K. Immunocytochemical study of myelination and oligodendrocyte in infants with periventricular leukolacia. Pediatr Neurol. 1995;13:296–304
  25. Li J, Baud O, Vartanian T, et al. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA. 2005;102:9936–9941
  26. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci. 2002;22:455–463
  27. Follett PL, Rosenberg PA, Volpe JJ, et al. Attenuates excitotoxic injury in developing white matter. J Neurosci. 2000;20:9235–9241
  28. Haynes RL, Borenstein NS, DeSilva TM, et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol. 2005;484:156–167
  29. Kadhim H, Tabarki B, Verellen G, et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology. 2001;56:1278–1284
  30. Buntinx M, Moreels M, Vandenabeele F, et al. Cytokine-induced cell death in human oligodendroglial cell lines (I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis). J Neurosci Res. 2004;76:834–845
  31. Okoshi Y, Mizuguchi M, Itoh M, et al. Altered nestin expression in the cerebrum in periventricular leukomalacia. Pediatr Neurol. 2007;36:170–174
  32. Petrini JR, Dias T, McCormick MC, et al. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 2009;154:169–176
  33. Back SA, Luo NL, Borenstein NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 2001;21:1302–1312
  34. Back SA, Luo NL, Borenstein NS, et al. Arrested oligodendrocyte lineage progression during human cerebral white matter development: Dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol. 2002;61:197–211
  35. Folkerth RD, Haynes RL, Borenstein NS, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol. 2004;63:990–999
  36. DeSilva TM, Kinney HC, Borenstein NS, et al. The glutamate transporter is transiently expressed in developing human cerebral white matter. J Comp Neurol. 2007;501:879–890
  37. Talos DM, Follett PL, Folkerth RD, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury (II. Human cerebral white matter and cortex). J Comp Neurol. 2006;497:61–77
  38. Billiards SS, Haynes RL, Folkerth RD, et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol. 2006;497:199–208
  39. Arai Y, Deguchi K, Takashima S. Vascular endothelial growth factor in brains with periventricular leukomalacia. Pediatr Neurol. 1998;19:45–49
  40. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol. 1978;35:11–16
  41. Marin-Padilla M. Developmental neuropathology and impact of perinatal brain damage (2. White matter lesions of the neocortex). J Neuropathol Exp Neurol. 1997;56:219–235
  42. Gilles FH, Leviton A, Golden JA, et al. Groups of histopathologic abnormalities in brains of very low birthweight infants. J Neuropathol Exp Neurol. 1998;57:1026–1034
  43. Douglas RM. Postnatal hypoxia and the developing brain: cellular and molecular mechanisms of injury. In:  Haddad GG,  Yu SP editor. Brain Hypoxia and Ischemia with Special Emphasis on Development. New York: Humana Press; 2009;p. 255–276
  44. Jensen FE. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr. 2006;18:628–633
  45. Panigrahy A, Bivm̈i S. Advances in magnetic neuroimaging techniques in the evaluation of neonatal encephalopathy. Top Magn Reson Imaging. 2007;18:3–29
  46. Peterson BS, Vohr B, Staib LH, et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA. 2000;284:1939–1947
  47. Martinussen M, Fischl B, Larsson HB, et al. Cerebral cortex thickness in 15-year-old adolescents with low birth weight measured by an automated MRI-based method. Brain. 2005;128:2588–2596
  48. Lin Y, Okumura A, Hayakawa F, et al. Quantitative evaluation of thalami and basal ganglia in infants with periventricular leukomalacia. Dev Med Child Neurol. 2001;43:481–485
  49. Inder TE, Huppi PS, Warfield S, et al. Periventricular white matter injury in the premature infant is associated with a reduction in cerebral cortical gray matter volume at term. Ann Neurol. 1999;46:755–760
  50. Isaacs E, Lucas A, Chong WK, et al. Hippocampal volume and everyday memory in children of very low birth weight. Pediatr Res. 2000;47:713–720
  51. Golden JA, Gilles FH, Rudelli R, et al. Frequency of neuropathological abnormalities in very low birth weight infants. J Neuropathol Exp Neurol. 1997;56:472–478
  52. Miller SP, Cozzio CC, Goldstein RB, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol. 2003;24:1661–1669
  53. Oberheim NA, Takano T, Han X, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276–3287
  54. Armstrong DL, Sauls CD, Goddard-Finegold J. Neuropathologic findings in short-term survivors of intraventricular hemorrhage. Am J Dis Child. 1987;141:617–621
  55. Kinney HC, Panigrahy A, Newburger JW, et al. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol (Berl). 2005;110:563–578
  56. Sidman RL, Rakic P. Development of the human central nervous system. In:  Adams RD,  Haymaker W editor. Cytology and Cellular Neuropathology. 2nd ed.. Springfield, IL: Thomas; 1973;
  57. Haynes RL, Folkerth RD, Szweda LI, et al. Physiological lipid peroxidation during the period of active myelination in the human cerebral white matter. J Neuropathol Exp Neurol. 2006;65:894–904
  58. Kinney HC, Brody BA, Kloman AS, et al. Sequence of CNS myelination in human infancy II (Patterns of myelination in autopsied infants). J Neuropathol Exp Neurol. 1988;47:217–234
  59. Provenzale JM, Liang L, DeLong D, et al. Diffusion tensor imaging assessment of brain white matter maturation during the first postnatal year. Am J Radiol. 2007;189:476–486
  60. Krueger XJ, Buja LM, Covinsky M. The impact of declining autopsy: need for revised healthcare policy. Am J Med Sci. 2009;337:41–46
  61. Saper DB. Any way you cut it: A new journal policy for the use of unbiased counting methods. J Comp Neurol. 1996;364:5
  62. Benes FM, Lange N. Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci. 2001;24:11–17
  63. Lechpammer M, Manning SM, Samonte F, et al. Minocycline treatment following hypoxic-ischemic injury attenuates white matter injury in a rodent model of periventricular leukomalacia. Neuropathol Appl Neurobiol. 2008;34:379–393
  64. Counsell SJ, Dyet LE, Larkman DJ, et al. Thalamo-cortical connectivity in children born preterm mapped using probabilistic magnetic resonance tractography. NeuroImage. 2007;34:896–904

 Supported by grants from the National Institute of Neurological Diseases and Stroke (PO1-NS38475), Hearst Foundation, March of Dimes, and National Institute of Child Health and Development (P30-HD18655) (Children's Hospital Developmental Disabilities Research Center).

PII: S1071-9091(09)00060-6

doi: 10.1016/j.spen.2009.09.003

Seminars in Pediatric Neurology
Volume 16, Issue 4 , Pages 179-190 , December 2009

Article Tools

* Image Usage & Resolution